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1. Introduction
Cancer is one of the leading causes of death for chil-
dren and adolescents around the world and approximately 
300,000 children aged 0 to 19 years old are diagnosed 
with cancer each year [1].
In comparison to world, India has a lower incidence of 
pediatric cancer. As per the report of International Inci-
dence of childhood cancer volume-3 (IICR-3), age-stand-
ardized rate of childhood cancer (0-19 year) incidence in 
India is 87.3 per million (pm) which is significantly lower 
than countries like US (180 pm), Canada (173.9 pm), Eu-
rope (170-190 pm) [1]. 
In India, data is collected through 33 population-based 
cancer registry and 29 hospital-based cancer registry 
which represents just 10% of population [2,3]. This high-
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Cancer is a leading cause of death for children and adolescent worldwide. 
The cure rates in low middle-income countries are dismal (20%) in 
comparison to high income countries (80%). The first move is to assemble 
precise data on epidemiology of pediatric cancer across the country and its 
region wide variation. This study attempts to provide spectrum of pediatric 
malignancies from a tertiary care hospital in the state of Rajasthan, India. 
A total of 140 cases were studied retrospectively over a period of two years 
(April 2018-March 2020). Patients, 0-18 years of age that are diagnosed 
as a case of malignancy were included in this study. The records of these 
patients were retrieved and analyzed. 
Patients were stratified in 4 groups; 0-4 years, 5-9 years, 10-14 years 
and 15-18 years. Most of the patients fell in 15-18 year group (35.7%), 
followed by 5-9 year group (28.5%). Majority of cases, 67.8% were male. 
The male to female ratio is 2.1:1. Leukemia (40%) was the most common 
malignancy followed by lymphoma, retinoblastoma and malignant bone 
tumors. Acute lymphoblastic leukemia comprises majority (35/56) of 
leukemia. Retinoblastoma was predominant malignancy among <5-year 
children. In all other groups, leukemia was predominant. 
This study gauges the trend of pediatric malignancies at one of the largest 
tertiary care hospitals in Rajasthan, which is important in the planning and 
evaluation of health strategies. As we lack a dedicated pediatric cancer 
registry, such epidemiological studies play a significant part for this small 
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lights our knowledge gap regarding the true incidence of 
pediatric cancer in our country due to under reporting. 
Hence, leading to less diversion of resources for the man-
agement of pediatric cancer care and resulting in dismal 
outcomes in comparison to the western world [3,4]. Moreo-
ver there is regional variation in reporting due to disparity 
in infrastructure and socioeconomic factors. Our study is 
an attempt to strengthen the pediatric cancer epidemiolog-
ical data and emphasize the demographic variations.
2. Material and Methods
It is a retrospective observational cohort study conduct-
ed over a period of two years (April 2018 to March 2020) 
in the department of medical oncology at a government 
tertiary health care cancer facility of Rajasthan after ob-
taining permission from concerned authority. The data 
of total 140 cases were collected from hospital records. 
All children aged 0-18 years, diagnosed as a case of ma-
lignancy by means of peripheral blood smears and bone 
marrow studies, cytological and histopathological ex-
amination during this period, were included in the study. 
Histological diagnosis was confirmed by our pathologist 
in all cases except for surgically inaccessible intracranial 
tumors. The records of these patients were retrieved and 
analyzed, focusing on the prevalence according to age, 
sex and types of tumors. For classification of pediatric 
malignancies in the present study, the International Classi-
fication of Childhood Cancers (ICCC), based on Interna-
tional Classification of Diseases for Oncology (ICD-O-3), 
was followed [5,6]. 
Statistical analysis
The data were entered in an EXCEL sheet and then 
analyzed. Descriptive statistics for continuous variables 
and frequency distribution, with their percentages were 
calculated as required.
3. Results
The data were recorded for 140 patients from age 0-18 
years. Patients were stratified in four groups i.e 0-4 year, 
5-9 year, 10-14 year and 15-18 year (Figure 1). Most of 
the patients (35.7 %) were placed in 15-18 year group 
(50/140), followed by 28.5% (40/140) patients in 5-9 year 
group. There were 18.5% and 17.1 % patients from age 
group 10-14 years (26/140) and 0-4 years (24/140). The 
mean and median age is 10.3 years and 11 years respec-
tively in the present study. Sex wise distribution: Majority 
of cases, 67.8% were male (95/140) in comparison to 
32.1% (45/140) were female (Figure 2). The male to fe-
male ratio is 2.1 in the current study. 
Figure 1. Stratification of patients as per age groups.
Figure 2. Sex wise distribution
Clinical Profile
Among all pediatric cancers, the most common was 
leukemia with 40% (56/140) of children affected (Fig-
ure 3/Table 1). The second most common was lympho-
ma 14.2% (20/140), followed by retinoblastoma 11.4% 
(16/140) and malignant bone tumors 10% (14/140). Germ 
cell tumor, neuroblastoma and renal tumors each consti-
tute five percent (6/140) cases. Soft tissue sarcoma and 
CNS neoplasm were 5% (7/140) and 1.4% (2/140) respec-
tively. Among others, there was a case of adrenocortical 
tumor in a 17-year-old boy. 
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Among the subgroup of leukemia, acute lymphoblas-
tic leukemia was the most common with 62.5% (35/56) 
cases. The most common age group affected was between 
15 to 18 years with male predominance. Acute myeloid 
leukemia was 10.7% (15/140) of all the cases. There 
were 4 cases of chronic myeloid leukemia, 3 of them lie 
in age group 15 to 18. There was 10-year-old boy hav-
ing myelodysplastic syndrome. Among the lymphoma 
subgroup, Hodgkin lymphoma was the commonest with 
7.1% (10/140) cases. There was again male predominance 
with only single female case out of 10. The most common 
age group affected was 15 to 18 years. There were 4.2% of 
non-Hodgkin lymphoma and 4 cases of unspecified lympho-
ma. Ewings sarcoma (7.1%) was the commonest bone tumor 
followed by osteosarcoma (2.1%). Most of our patients (80%) 
were started on treatment protocol as per the diagnosis (Figure 
4). Seven percent refused for further treatment and 13% were 
referred to palliative or best supportive care. 
Figure 4. Follow up of the study cohort
4. Discussion
Childhood cancers are often neglected as they represent 
a small proportion of all cancers (0.7-4.4%) [3,7]. On the 
other hand when it occurs, it requires medical, psycholog-
ical and societal concern. Childhood cancer incidence ap-
pears to be increasing in India [3,8]. As we contain the mor-
bidity and mortality caused by infection and malnutrition, 
childhood cancer attain increasing priority in our country. 
In the report of International Incidence of childhood 
cancer volume-3 (IICR-3), age-standardized rate of child-
hood cancer (0-19 year) incidence in India is 87.3 pm 
which is quite lower than countries like US (180 pm), 
Canada (173.9 pm) or Europe (170-190 pm) [1]. This 
discrepancy can be explained by delay in diagnosis, un-
der-reporting, poor health care access, centralization of 
resources, less than 10% population coverage by cancer 
registries. ‘Missing’ cases can be attributed to myriad of 
reasons ranging from societal to availability of health care 
services [3].
In this study, we retrospectively analyzed the data re-
garding demographics and spectrum of malignancies in 
140 pediatric patients (0-18 years) in a span of two years 
attending our tertiary health care facility.
As per IICR-3 [1], ASRs were higher in children aged 
0-4 years (ASR 197.1 pm) and 15-19 years (ASR 185.3 
pm) than in those aged 5-9 years and 10-14 years. Similar 
observation made in our study for the age group 15-18 
Table 1. Distribution of various cancers along the age groups




ALL 0 12 7 16 35
56 (40%)
AML 1 3 3 8 12
CML 0 0 1 3 04
MDS 0 0 1 0 01
Unspecified 0 0 1 0 01
2. LYMPHOMA
Hodgkin lymphoma 0 3 1 6 10
20 (14.2%)NHL 2 2 0 2 06
OTHER 1 1 2 0 04
3 CNS NEOPLASMS 1 0 1 0 02 2(1.4%)
4 NEUROBLASTOMA 1 3 0 2 06 6 (4.2%)
5 RETINOBLASTOMA 9 5 1 1 16 16 (11.4%)
6 RENAL TUMORS (Wilms tumor) 3 3 0 0 06 6 (4.2%)
7 HEPATIC TUMORS 0 0 0 0 00 0
8 BONE TUMORS
Osteosarcoma 0 0 1 2 03
14 (10%)Ewing sarcoma 1 2 4 3 10
Other 0 0 0 1 01
9 SOFT TISSUE SARCOMA
Rhabdomyosarcoma 1 1 0 1 03
7(5%)
Other STS 1 2 1 0 04
10 GERM CELL TUMOR 2 1 0 3 06 6(4.2%)
11 CARCINOMA AND MELANOMA 1 0 0 1 02 2 (1.4%)
12 OTHERS AND UNSPECIFIED 0 2 2 1 05 5 (3.5%)
Total 24 40 26 50 140 140
Percentage 17.1% 28.5% 18.5% 35.7% 100%
DOI: https://doi.org/10.30564/jor.v3i2.3645
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years of age (35.7%; 50/140 cases), but not for 0-4 years. 
The possible explanation can be that this age group of 0-4 
years is obtaining treatment at the pediatric centre of our 
institute. 
Incidence rates are slightly higher in boys than in girls 
(incidence sex ratio 1•14 in the 0-19 years age-group) and 
varied with age, region, and diagnostic group [1,3]. In IICR-
3, the highest sex ratio incidence was reported from India 
(1.56) compared to 1.12-1.15 in high income countries (3). 
In our study, males were affected in 65.7% (95/140), while 
females were affected in 34.3% (45/140) cases. M: F ratio 
was 2.1:1. Similarly, Jussawalla et al [9] (1.7), Das et al [10] 
(2), Nandkumar et al [11] (1.8), Chauhan et al [12] (2.2) and 
Bryan et al [13] (4) reported high sex ratios in their studies. 
Although according to Kusumakumary et al [14], male pre-
dominance is a salient feature of many childhood tumors. 
This high ratio cannot be explained solely biologically or 
genetically but a large number of socio-cultural practices 
play in their part. Gender-based discrimination is seen 
in Southeast Asian countries which results into delayed 
healthcare seeking for all childhood illnesses including 
cancer [3,15].
Childhood cancers are more commonly derived from 
hematopoietic system, central nervous system, soft tissue, 
bone and kidney in contrast to adults in whom skin, lung, 
breast, prostate and colon are the mostly affected [16]. The 
three most common tumor in our study were leukemia 
(56/140; 40%), lymphoma (20/140;14.2%) and retinoblas-
toma (16/140;11.4%). Bhalodia et al. [17], Pattnaik et al. [18], 
Jan M et al. [19], Chauhan et al [12] and Chaudhuri et al. [20] 
also reported leukemia as the most common pediatric ma-
lignancy in their studies. IICR-3 [1] also reports leukemia 
as the most common cancer for 0-14 year but lymphoma 
among 15-19 year. Lymphoma comprises 16% (8/50) of 
patient among 15-18 year in this study. Our data found 
retinoblastoma as the most common malignancy among 
0-4 year (9/24; 37.5%). Similar findings were reported by 
Jabeen et al [21] and Hazarika et al [22]. Leukemia was the 
most common malignancy among all other age groups 
(37-54%).
Malignant bone tumors were present in 10% (14/140) 
of our patients. This is in concordance with Pattnaik et 
al. [18], Chauhan et al. [12] and Devi S et al [23]. As in IICR-
3 [1], renal tumors were common in children aged 0-4 
years (3/24;12%) and 5-9 year (3/40;7.5%) and frequency 
decreased in older age groups (0%). ALL was the most 
commonly seen hematological malignancy (62%; 35/56 
cases). This was in concordance with the studies of Bhalo-
dia et al. [17], Satyanarayana et al. [8], Pattnaik et al. [18] and 
Chauhan et al [12]. Retinoblastoma was the most common 
non-hematological malignancy (16/64; 25%) followed by 
Ewing sarcoma (10/64; 15.6%). Chaudhuri et al. [20] also 
reported retinoblastoma as the most common non-hemato-
logical malignancy (19.2%). There was no case of hepatic 
tumor in our cohort and CNS neoplasm was observed in 
only 1.4% (2/140) cases. This may be due to delay in di-
agnosis, poor availability of imaging techniques and their 
prohibitive cost.
A SIOP report stressed that refusal; non-compliance 
and abandonment of medical treatment remain critical 
issue [24]. Although most of the patients (80%) in our study 
were started on disease-based protocol, further follow up 
data could not be retrieved. Twenty percent were not giv-
en disease specific treatment as few (7%; 10/140) refused 
and rest (13%; 19/140) had very advanced disease. Arora 
et al [25] reiterates the problem of abandonment in the 
developing countries for child hood cancer and suggests 
ways to improve treatment adherence.
Hence, we notice that various studies have shown in-
consistent pattern of childhood cancer from our country. 
Retinoblastoma and leukemia were the most common 
malignancy in 0-4 year and 5-18-year group respectively. 
Leukemia, lymphoma, bone tumor and germ cell tumor 
occurred more commonly above five years of age, while 
retinoblastoma and Wilm’s tumor were seen mostly in 
children less than five years. 
Limitation
The present study is a single institution-based study. 
Small sample size and lack of follow-up served as a limi-
tation.
5. Conclusions
This study gauges the trend of pediatric malignancies 
in Rajasthan, which is important in the planning and eval-
uation of health strategies. In India, where there is dearth 
of high-quality data as we lack a dedicated pediatric can-
cer registry, such epidemiological studies play a signifi-
cant part for this small but distinguished group of patients.
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